Overall, researchers are estimating that there will be 310,720 new cases of invasive breast cancer and 56,500 new cases of ...

Medicaid expansion was associated with earlier diagnosis, more timely initiation of guideline-concordant care, and better ...

Sen. JD Vance and Gov. Tim Walz met in an Oct. 1 vice presidential debate that was heavy on policy discussion.

Researchers found that patients diagnosed with HCC during 2013-2019 were less likely to die from HCC or from any cause than patients who were diagnosed during 2006-2012.

Lu-Dotatate may be considered “a rational therapeutic choice” for patients with refractory meningioma, according to Kenneth Merrell, MD.

The HYPOSIB trial supports moderately hypofractionated radiotherapy with simultaneous boost as a standard-of-care option that ...

High-dose radiotherapy “needs the addition of short-term ADT to improve outcomes in intermediate- and high-risk localized ...

Zachary W. Schulz, a public health historian, compares Kamala Harris's and Donald Trump's records on health care.

Patients who received subcutaneous daratumumab plus bortezomib, lenalidomide, and dexamethasone (VRd) had better outcomes ...

Researchers surveyed medical oncology fellows to assess the perceived impact of abortion restrictions on cancer care and how ...

Rates of late biochemical recurrence and progression to metastasis were “strikingly low” in patients with pT2 stage disease and Gleason scores less than or equal to 3 + 4.

Children with ALL who are MRD negative at the end of first consolidation do not require further MRD assessments, researchers say.